Form 4 · Filed Jun 24, 2026, 11:24 PM UTC
SEPN/Septerna, Inc.
Long Daniel D. — SVP, Drug Discovery
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | M | other | 10,529 | $3 | $29,060 | 106,941 |
| Jun 22, 2026 | M | other | 4,471 | $12 | $52,311 | 111,412 |
| Jun 22, 2026 | S | sell | 8,000 | $35 | $280,801 | 103,412 |
| Jun 22, 2026 | S | sell | 7,000 | $36 | $251,781 | 96,412 |
| Jun 22, 2026 | M | other | 10,529 | — | — | 10,376 |
| Jun 22, 2026 | M | other | 4,471 | — | — | 25,529 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-281461